Medtech giant Medtronic has decided not to go ahead with a planned acquisition of EOFlow, a developer of patch-based insulin pumps, saying that there have been “multiple breaches” of their ...

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...

Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...

Medical device specialist Medtronic ( MDT 1.05%) has long been a solid dividend stock -- and it has upped its payout for ...

What Happened: Disclosed in a Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission, Martha, Chairman and CEO at Medtronic, executed a strategic derivative sale. This involved ...

What Happened: The latest Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission uncovered Walter, SVP at Medtronic, exercising stock options for 1,337 shares of MDT. The total ...

The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Medtronic hired a new chief financial officer away from French carmaker Renault. Thierry Pieton, chief financial officer of ...

One system consisted of a Stockert SIII roller pump (Sorin Group USA, Arvada, CO) with a Tygon S-95 tubing raceway (Saint-Gobain Performance Plastics, Portage, WI), a Medtronic 0800 or 1500 ...